Adam Maeder
Stock Analyst at Piper Sandler
(4.66)
# 851
Out of 4,703 analysts
369
Total ratings
55.1%
Success rate
12.8%
Average return
Main Sectors:
Stocks Rated by Adam Maeder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LIVN LivaNova | Reiterated: Buy | $87 → $90 | $81.92 | +9.86% | 34 | Sep 2, 2026 | |
| ABT Abbott Laboratories | Maintained: Buy | $118 | $108.33 | +8.93% | 20 | Aug 26, 2026 | |
| ISRG Intuitive Surgical | Maintained: Buy | $470 | $366.70 | +28.17% | 52 | Aug 21, 2026 | |
| STAA STAAR Surgical Company | Reiterated: Hold | $33 | $23.47 | +40.61% | 7 | Aug 13, 2026 | |
| RMD ResMed | Maintained: Hold | $233 → $225 | $228.35 | -1.47% | 8 | Aug 7, 2026 | |
| GKOS Glaukos | Maintained: Buy | $195 | $177.47 | +9.88% | 18 | Aug 7, 2026 | |
| NYXH Nyxoah | Reiterated: Buy | $7 → $6 | $1.62 | +270.37% | 26 | Aug 6, 2026 | |
| SGHT Sight Sciences | Reiterated: Buy | $9 | $8.35 | +7.78% | 9 | Aug 6, 2026 | |
| RXST RxSight | Maintained: Hold | $10 | $6.38 | +56.86% | 10 | Aug 6, 2026 | |
| INSP Inspire Medical Systems | Maintained: Hold | $55 → $60 | $63.08 | -4.88% | 50 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $0.8532 | +251.62% | 8 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $101 | $89.90 | +12.35% | 56 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $3.5 | $1.39 | +151.80% | 18 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $21.87 | +92.04% | 25 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5.5 → $3 | $2.88 | +4.17% | 13 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8.5 → $7 | $0.038904 | n/a | 12 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $74 | $51.96 | n/a | 1 | Apr 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.45 → $2.07 | $0.17 | n/a | 2 | Dec 23, 2019 |
LivaNova
Sep 2, 2026
Reiterated: Buy
Price Target: $87 → $90
Current: $81.92
Upside: +9.86%
Abbott Laboratories
Aug 26, 2026
Maintained: Buy
Price Target: $118
Current: $108.33
Upside: +8.93%
Intuitive Surgical
Aug 21, 2026
Maintained: Buy
Price Target: $470
Current: $366.70
Upside: +28.17%
STAAR Surgical Company
Aug 13, 2026
Reiterated: Hold
Price Target: $33
Current: $23.47
Upside: +40.61%
ResMed
Aug 7, 2026
Maintained: Hold
Price Target: $233 → $225
Current: $228.35
Upside: -1.47%
Glaukos
Aug 7, 2026
Maintained: Buy
Price Target: $195
Current: $177.47
Upside: +9.88%
Nyxoah
Aug 6, 2026
Reiterated: Buy
Price Target: $7 → $6
Current: $1.62
Upside: +270.37%
Sight Sciences
Aug 6, 2026
Reiterated: Buy
Price Target: $9
Current: $8.35
Upside: +7.78%
RxSight
Aug 6, 2026
Maintained: Hold
Price Target: $10
Current: $6.38
Upside: +56.86%
Inspire Medical Systems
Aug 4, 2026
Maintained: Hold
Price Target: $55 → $60
Current: $63.08
Upside: -4.88%
Jul 31, 2026
Maintained: Buy
Price Target: $3
Current: $0.8532
Upside: +251.62%
Jul 24, 2026
Reiterated: Buy
Price Target: $100 → $101
Current: $89.90
Upside: +12.35%
May 13, 2026
Reiterated: Buy
Price Target: $4 → $3.5
Current: $1.39
Upside: +151.80%
May 5, 2026
Reiterated: Buy
Price Target: $42
Current: $21.87
Upside: +92.04%
Apr 7, 2026
Maintained: Buy
Price Target: $5.5 → $3
Current: $2.88
Upside: +4.17%
Aug 13, 2025
Maintained: Hold
Price Target: $8.5 → $7
Current: $0.038904
Upside: n/a
Apr 9, 2020
Initiated Coverage: Buy
Price Target: $74
Current: $51.96
Upside: n/a
Dec 23, 2019
Reiterated: Buy
Price Target: $3.45 → $2.07
Current: $0.17
Upside: n/a